Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

This study has been terminated.
(Study stopped due to increased cardiovascular risks associated with Celebrex)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00073970
First received: December 10, 2003
Last updated: May 21, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2006
  Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)